Literature DB >> 16482817

[Serum levels for IgM and IgA antibodies to anti-trypanosoma cruzi in samples of blood from newborns from mothers with positive serology for Chagas disease].

Patricia Rodriguez1, Carine Truyens, Cristina Alonso-Vega, Amilcar Flores, Marisol Cordova, Eduardo Suarez, Faustino Torrico, Yves Carlier.   

Abstract

This study compares the levels of specific antibodies IgM and IgA for Chagas in samples of blood from newborns. Three groups of cord blood samples have been analysed: a group of 42 samples from newborns, displaying positive parasitemia, of seropositive mothers (M+B+), 68 samples from newborns with negative parasitemia whose mothers were seropositive (M+B-) and a group of 45 control newborns coming from mothers with negative serology for Chagas. From the 42 M+B+ samples with congenital Chagas disease, 81 and 82.9% displayed detectable levels of IgM and IgA antibodies, respectively In the M+B- group, 70.6 and 33.8% presented antibodies of IgM and IgA classes, respectively, whereas in the control group M-B-, we detected 6% and 11.1% of IgM and IgA antibodies, respectively. The calculated sensitivity of detection of congenital cases using IgM or IgA antibodies was of 82.9% and 80.9% respectively, whereas the specificity of detection was of 29.4% for IgM antibodies and of 66.1% for IgA antibodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16482817

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  6 in total

1.  The Immunoglobulin M-Shed Acute Phase Antigen (SAPA)-test for the Early Diagnosis of Congenital Chagas Disease in the Time of the Elimination Goal of Mother-to-Child Transmission.

Authors:  Yagahira E Castro-Sesquen; Freddy Tinajeros; Caryn Bern; Gerson Galdos-Cardenas; Edith S Malaga; Edward Valencia Ayala; Kathryn Hjerrild; Steven J Clipman; Andrés G Lescano; Tabitha Bayangos; Walter Castillo; María Carmen Menduiña; Kawsar R Talaat; Robert H Gilman
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079

Review 2.  Chagas Disease in the United States: a Public Health Approach.

Authors:  Caryn Bern; Louisa A Messenger; Jeffrey D Whitman; James H Maguire
Journal:  Clin Microbiol Rev       Date:  2019-11-27       Impact factor: 26.132

3.  Towards a New Strategy for Diagnosis of Congenital Trypanosoma cruzi Infection.

Authors:  Alba Abras; Carmen Muñoz; Cristina Ballart; Pere Berenguer; Teresa Llovet; Mercedes Herrero; Silvia Tebar; María-Jesús Pinazo; Elizabeth Posada; Carmen Martí; Victoria Fumadó; Jordi Bosch; Oriol Coll; Teresa Juncosa; Gemma Ginovart; Josep Armengol; Joaquim Gascón; Montserrat Portús; Montserrat Gállego
Journal:  J Clin Microbiol       Date:  2017-02-15       Impact factor: 5.948

Review 4.  Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.

Authors:  Carmen Muñoz; Montserrat Gállego; Alba Abras; Cristina Ballart; Anna Fernández-Arévalo; María-Jesús Pinazo; Joaquim Gascón
Journal:  Clin Microbiol Rev       Date:  2022-03-03       Impact factor: 50.129

5.  Fatal congenital Chagas' disease in a non-endemic area: a case report.

Authors:  María Flores-Chávez; Yamile Faez; José M Olalla; Israel Cruz; Teresa Gárate; Mercedes Rodríguez; Pilar Blanc; Carmen Cañavate
Journal:  Cases J       Date:  2008-11-07

6.  Is Antibody-Dependent Enhancement of Trypanosoma cruzi Infection Contributing to Congenital/Neonatal Chagas Disease?

Authors:  Yves Carlier; Carine Truyens; Eric Muraille
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.